Morgan Stanley’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.2B | Sell |
15,437,458
-155,561
| -1% | -$158M | 0.86% | 14 |
|
|
2025
Q4 | $16.8B | Buy |
15,593,019
+407,166
| +3% | +$389M | 1% | 11 |
|
|
2025
Q3 | $11.6B | Buy |
15,185,853
+317,357
| +2% | +$236M | 0.7% | 18 |
|
|
2025
Q2 | $11.6B | Sell |
14,868,496
-5,870
| -0% | -$4.56M | 0.76% | 17 |
|
|
2025
Q1 | $12.3B | Buy |
14,874,366
+495,270
| +3% | +$412M | 0.88% | 14 |
|
|
2024
Q4 | $11.1B | Sell |
14,379,096
-177,046
| -1% | -$147M | 0.78% | 16 |
|
|
2024
Q3 | $12.9B | Buy |
14,556,142
+834,139
| +6% | +$750M | 0.94% | 11 |
|
|
2024
Q2 | $12.4B | Buy |
13,722,003
+652,440
| +5% | +$522M | 0.96% | 11 |
|
|
2024
Q1 | $10.2B | Sell |
13,069,563
-12,251,871
| -48% | -$8.72B | 0.82% | 13 |
|
|
2023
Q4 | $14.8B | Buy |
25,321,434
+12,775,862
| +102% | +$7.46B | 0.65% | 19 |
|
|
2023
Q3 | $6.74B | Buy |
12,545,572
+83,915
| +0.7% | +$43.2M | 0.69% | 15 |
|
|
2023
Q2 | $5.84B | Buy |
12,461,657
+318,198
| +3% | +$133M | 0.58% | 23 |
|
|
2023
Q1 | $4.17B | Buy |
12,143,459
+84,255
| +0.7% | +$28.4M | 0.45% | 37 |
|
|
2022
Q4 | $4.41B | Buy |
12,059,204
+3,691,436
| +44% | +$1.31B | 0.5% | 30 |
|
|
2022
Q3 | $2.71B | Buy |
8,367,768
+864,625
| +12% | +$274M | 0.37% | 50 |
|
|
2022
Q2 | $2.43B | Buy |
7,503,143
+3,529,744
| +89% | +$1.06B | 0.32% | 59 |
|
|
2022
Q1 | $1.14B | Buy |
3,973,399
+150,539
| +4% | +$38.7M | 0.15% | 146 |
|
|
2021
Q4 | $1.06B | Buy |
3,822,860
+44,831
| +1% | +$11.4M | 0.13% | 165 |
|
|
2021
Q3 | $873M | Sell |
3,778,029
-44,790
| -1% | -$11.1M | 0.12% | 179 |
|
|
2021
Q2 | $877M | Buy |
3,822,819
+289,490
| +8% | +$58.2M | 0.12% | 178 |
|
|
2021
Q1 | $660M | Buy |
3,533,329
+155,365
| +5% | +$30.4M | 0.1% | 202 |
|
|
2020
Q4 | $570M | Buy |
3,377,964
+365,026
| +12% | +$54.5M | 0.09% | 206 |
|
|
2020
Q3 | $446M | Buy |
3,012,938
+265,526
| +10% | +$41.1M | 0.09% | 209 |
|
|
2020
Q2 | $451M | Sell |
2,747,412
-122,639
| -4% | -$18.8M | 0.1% | 188 |
|
|
2020
Q1 | $398M | Sell |
2,870,051
-381,494
| -12% | -$52.4M | 0.11% | 180 |
|
|
2019
Q4 | $427M | Buy |
3,251,545
+646,274
| +25% | +$74.9M | 0.1% | 197 |
|
|
2019
Q3 | $291M | Sell |
2,605,271
-512,017
| -16% | -$57M | 0.08% | 250 |
|
|
2019
Q2 | $345M | Sell |
3,117,288
-1,406,626
| -31% | -$166M | 0.09% | 221 |
|
|
2019
Q1 | $587M | Buy |
4,523,914
+441,533
| +11% | +$53.7M | 0.17% | 134 |
|
|
2018
Q4 | $472M | Sell |
4,082,381
-628,314
| -13% | -$70.2M | 0.14% | 155 |
|
|
2018
Q3 | $506M | Buy |
4,710,695
+237,158
| +5% | +$23.7M | 0.13% | 165 |
|
|
2018
Q2 | $382M | Buy |
4,473,537
+1,227,888
| +38% | +$101M | 0.1% | 203 |
|
|
2018
Q1 | $251M | Sell |
3,245,649
-2,197,040
| -40% | -$177M | 0.07% | 278 |
|
|
2017
Q4 | $460M | Buy |
5,442,689
+584,222
| +12% | +$49.7M | 0.13% | 168 |
|
|
2017
Q3 | $416M | Buy |
4,858,467
+41,855
| +0.9% | +$3.43M | 0.12% | 174 |
|
|
2017
Q2 | $396M | Buy |
4,816,612
+128,251
| +3% | +$10.5M | 0.12% | 181 |
|
|
2017
Q1 | $394M | Buy |
4,688,361
+663,263
| +16% | +$53.1M | 0.12% | 180 |
|
|
2016
Q4 | $296M | Buy |
4,025,098
+985,762
| +32% | +$73.4M | 0.1% | 220 |
|
|
2016
Q3 | $244M | Buy |
3,039,336
+238,661
| +9% | +$19.1M | 0.08% | 269 |
|
|
2016
Q2 | $221M | Sell |
2,800,675
-579,569
| -17% | -$43.6M | 0.08% | 276 |
|
|
2016
Q1 | $243M | Sell |
3,380,244
-130,154
| -4% | -$9.85M | 0.09% | 242 |
|
|
2015
Q4 | $296M | Buy |
3,510,398
+459,759
| +15% | +$38.2M | 0.11% | 215 |
|
|
2015
Q3 | $255M | Sell |
3,050,639
-601,096
| -16% | -$50.7M | 0.09% | 238 |
|
|
2015
Q2 | $305M | Buy |
3,651,735
+37,553
| +1% | +$2.86M | 0.11% | 218 |
|
|
2015
Q1 | $263M | Buy |
3,614,182
+69,155
| +2% | +$4.92M | 0.1% | 243 |
|
|
2014
Q4 | $245M | Buy |
3,545,027
+914,097
| +35% | +$61.7M | 0.09% | 252 |
|
|
2014
Q3 | $171M | Sell |
2,630,930
-58,068
| -2% | -$3.68M | 0.07% | 326 |
|
|
2014
Q2 | $167M | Buy |
2,688,998
+288,573
| +12% | +$17.2M | 0.07% | 330 |
|
|
2014
Q1 | $141M | Sell |
2,400,425
-598,127
| -20% | -$33.4M | 0.06% | 360 |
|
|
2013
Q4 | $153M | Sell |
2,998,552
-667,191
| -18% | -$33.4M | 0.07% | 332 |
|
|
2013
Q3 | $184M | Sell |
3,665,743
-981,484
| -21% | -$51.4M | 0.09% | 254 |
|
|
2013
Q2 | $228M | Buy |
+4,647,227
| New | +$253M | 0.12% | 215 |
|
Other funds holding LLY
VCM
VPM
Morgan Stanley's LLY Position: Q1 2026 in Review
Morgan Stanley reduced its Eli Lilly (LLY) stake by 1% in Q1 2026, selling an estimated $158M and leaving 15,437,458 shares worth $14.2B. The position accounts for 0.86% of the portfolio, ranked #14.
Morgan Stanley first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.8B in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Morgan Stanley held 15,437,458 shares of Eli Lilly worth $14.2B as of Q1 2026.
- Morgan Stanley sold 155,561 Eli Lilly shares in Q1 2026, an estimated $158M.
- Eli Lilly made up 0.86% of Morgan Stanley's portfolio in Q1 2026, its #14 holding.
- Morgan Stanley first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Eli Lilly position peaked at $16.8B in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.